Session » (0357–0386) Patient Outcomes, Preferences, & Attitudes Poster I

Date: Sunday, October 26, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 0359

“VA is a slow-moving ship, but you can steer it”: Clinician Views on Navigating Shared Decision-Making and Anticipated Use of an RA Decision Aid

10:30AM-12:30PM: Abstract Number: 0376

An Internet-Delivered, Arthritis-Tailored Cognitive Behavioral Therapy for Insomnia Program for People with Co-Morbid Sleep Disturbance: Comparing Baseline Characteristics of Cannabis Users and Non-Users

10:30AM-12:30PM: Abstract Number: 0374

Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic

10:30AM-12:30PM: Abstract Number: 0360

Assessing Content Validity of a New Questionnaire Evaluating Glucocorticoid Toxicity

10:30AM-12:30PM: Abstract Number: 0363

Assessing Whole Health Needs in Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 0375

Association of Glucocorticoid Toxicity Index Scores with Quality-of-Life and Healthcare Resource Utilization at 6 Months in a Real-World Cohort of Individuals Receiving Glucocorticoids

10:30AM-12:30PM: Abstract Number: 0365

Clinical Characteristics and Psychosocial Outcomes of Patients with UCTD Compared to SLE

10:30AM-12:30PM: Abstract Number: 0357

Content validation of patient-reported outcome (PRO) measures for fatigue, physical function and disease activity in Polymyositis (PM)

10:30AM-12:30PM: Abstract Number: 0366

Dental Findings in Patients With Rheumatic Diseases and Its Association With Self-Perceived Oral Health

10:30AM-12:30PM: Abstract Number: 0372

Development and Implementation of a Remote Educational Program to Optimize Safe Medication Use in Older Veterans with Rheumatic Diseases

10:30AM-12:30PM: Abstract Number: 0367

Differences in Self-Reported Medication Nonadherence and its Drivers in Young Adults versus Older Adults with Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 0358

Different Perspectives between Physicians and Patients on Treatment Priorities and Challenges in Still’s Disease

10:30AM-12:30PM: Abstract Number: 0379

Do Rheumatoid Arthritis Patients have Residual Fatigue Without Swollen Joints and Laboratory Inflammation? A Multicenter Study

10:30AM-12:30PM: Abstract Number: 0362

Drug Persistence of IL-17A Inhibitors Among Patients with PsA: Real-World Data from the CorEvitas PsA/SpA Registry

10:30AM-12:30PM: Abstract Number: 0368

Factors Associated with Patient Acceptability of Rheumatology Care Delivered by Telemedicine

10:30AM-12:30PM: Abstract Number: 0364

Group-Based Medical Mistrust and Logistical Factors Influencing Rheumatology Clinical Trial Enrollment: A Single-Center Cross-Sectional Survey

10:30AM-12:30PM: Abstract Number: 0383

Hidden Risk in Low Frailty: Impact of Elixhauser Comorbidities on In-Hospital Mortality Among Osteoporosis Patients — A Nationwide Analysis

10:30AM-12:30PM: Abstract Number: 0384

Hip Fracture Hospitalization Trends in Osteoporotic Patients (2016–2022): National Data Insights

10:30AM-12:30PM: Abstract Number: 0378

Identifying Patterns of Telemedicine Readiness and Digital Health Literacy in Rheumatoid Arthritis Patients: A Latent Class Analysis

10:30AM-12:30PM: Abstract Number: 0373

Implementation of a Lupus Self-Management mHealth App: Using Incentives to Drive Engagement

10:30AM-12:30PM: Abstract Number: 0381

Improving Participation in The Lupus Foundation of America’s Research Accelerated by You (RAY) Patient Registry By Understanding Patient Preference in Communication Strategies

10:30AM-12:30PM: Abstract Number: 0386

Introducing the Multidimensional Pain Inventory as a Comprehensive Tool or Assessing Pain in Patients With Axial Spondyloarthritis

10:30AM-12:30PM: Abstract Number: 0371

Lifestyle Coaching in Psoriatic Arthritis: Pilot Findings from an Online eCoaching Program

10:30AM-12:30PM: Abstract Number: 0380

Multidimensional Health Assessment Questionnaire (MDHAQ)/RAPID3, is an Useful Tool to Assess Comorbid and Residual Fatigue in Rheumatoid Arthritis Patients

10:30AM-12:30PM: Abstract Number: 0385

Musculoskeletal Ultrasound Enhances Patient Insight and Clinical Decisions: A Multi-Center Study

10:30AM-12:30PM: Abstract Number: 0377

New efforts to incorporate patient-reported outcomes into clinical trials for lupus therapeutics

10:30AM-12:30PM: Abstract Number: 0370

Patient Preferences for Treatments of Rheumatoid Arthritis: A Discrete Choice Experiment Evaluating Preference for Advanced Drug Therapies and Neuroimmune Modulation Device

10:30AM-12:30PM: Abstract Number: 0382

Preventative Health Screening Practices Among 666 Women with Systemic Rheumatic Diseases from the Hospital for Special Surgery Rheumatology Women’s Reproductive Health and Wellness Cohort: A Cross-Sectional Analysis

10:30AM-12:30PM: Abstract Number: 0369

Real-World Persistence of Janus Kinase Inhibitors in Biologic-Experienced Patients with Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 0361

Transition in Focus: Health Care Utilization and Disease Status in Youth with Connective Tissue Diseases— A Single-Center Experience in British Columbia, Canada

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].